NMPA Approval

Composite Potassium Hydrogen Phosphate Injection

Approval Number

国药准字H20254014

Company南京恩泰医药科技有限公司

Registration Date

April 30, 2025

Drug Information

Generic Name

复合磷酸氢钾注射液

Dosage Form

注射剂

Strength

5ml：磷酸二氢钾1.12g和磷酸氢二钾（按K₂HPO₄计）1.18g

Drug Type

化学药品

Registration Date

April 30, 2025

Company Information

Applicant Company

Company Name南京恩泰医药科技有限公司

Company Address

南京市栖霞区仙林街道纬地路9号江苏生命科技园C6栋703室、705-710室

Manufacturing Company

Company Name江苏大红鹰恒顺药业有限公司

Company Address

江苏省沭阳经济技术开发区宁波路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.